Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer

par Miyata, Yasuyoshi, Matsuo, Tomohiro, Araki, Kyohei, Nakamura, Yuichiro, Sagara, Yuji, Ohba, Kojiro, Sakai, Hideki
Publié dans Medicines (Basel) (2018)

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Co...

par Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Publié dans Medicines (Basel) (2018)

Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder

par Matsuo, Tomohiro, Miyata, Yasuyoshi, Araki, Kyohei, Mukae, Yuta, Otsubo, Asato, Ohba, Kojiro, Sakai, Hideki
Publié dans Low Urin Tract Symptoms (2019)

Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded...

par Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Publié dans Medicines (Basel) (2020)

Four-weekly Low-dose Gemcitabine and Paclitaxel in Patients With Platinum-resistant Urothelial Cancer and Performance Status 2/3

par ARAKI, KYOHEI, MIYATA, YASUYOSHI, NAKAMURA, YUICHIRO, MUKAE, YUTA, OTSUBO, ASATO, YUNO, TSUTOMU, MITSUNARI, KENSUKE, MATSUO, TOMOHIRO, OHBA, KOJIRO, SAKAI, HIDEKI
Publié dans In Vivo (2019)

Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1

par Mukae, Yuta, Miyata, Yasuyoshi, Nakamura, Yuichiro, Araki, Kyohei, Otsubo, Asato, Yuno, Tsutomu, Mitsunari, Kensuke, Matsuo, Tomohiro, Ohba, Kojiro, Sakai, Hideki
Publié dans Oncol Lett (2020)

Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study

par AIBARA, NOZOMI, MIYATA, YASUYOSHI, ARAKI, KYOHEI, SAGARA, YUJI, MITSUNARI, KENSUKE, MATSUO, TOMOHIRO, OHBA, KOJIRO, MOCHIZUKI, YASUSHI, SAKAI, HIDEKI, OHYAMA, KANAME
Publié dans In Vivo (2021)

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A prelimi...

par Miyata, Yasuyoshi, Araki, Kyohei, Ohba, Kojiro, Mastuo, Tomhiro, Nakamura, Yuichiro, Yuno, Tsutomu, Mukai, Yuta, Otsubo, Asato, Mitsunari, Kensuke, Mochizuki, Yasushi, Sakai, Hideki
Publié dans Mol Clin Oncol (2020)

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A prelimi...

par Miyata, Yasuyoshi, Araki, Kyohei, Ohba, Kojiro, Mastuo, Tomhiro, Nakamura, Yuichiro, Yuno, Tsutomu, Mukai, Yuta, Otsubo, Asato, Mitsunari, Kensuke, Mochizuki, Yasushi, Sakai, Hideki
Publié dans Mol Clin Oncol (2020)

Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer

par HARADA, JUNKI, MIYATA, YASUYOSHI, ARAKI, KYOHEI, MATSUDA, TSUYOSHI, NAGASHIMA, YOSHIAKI, MUKAE, YUTA, MISTUNARI, KENSUKE, MATSUO, TOMOHIRO, OHBA, KOJIRO, MOCHIZUKI, YASUSHI, SAKAI, HIDEKI
Publié dans In Vivo (2021)